340 related articles for article (PubMed ID: 35547744)
1. CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives.
Chan YT; Lu Y; Wu J; Zhang C; Tan HY; Bian ZX; Wang N; Feng Y
Theranostics; 2022; 12(7):3329-3344. PubMed ID: 35547744
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 as precision and high-throughput genetic engineering tools in gastrointestinal cancer research and therapy.
Hosseini SA; Salehifard Jouneghani A; Ghatrehsamani M; Yaghoobi H; Elahian F; Mirzaei SA
Int J Biol Macromol; 2022 Dec; 223(Pt A):732-754. PubMed ID: 36372102
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-cas9: a powerful tool towards precision medicine in cancer treatment.
Xing H; Meng LH
Acta Pharmacol Sin; 2020 May; 41(5):583-587. PubMed ID: 31792341
[TBL] [Abstract][Full Text] [Related]
4. A review on CRISPR/Cas: a versatile tool for cancer screening, diagnosis, and clinic treatment.
Yang X; Zhang B
Funct Integr Genomics; 2023 May; 23(2):182. PubMed ID: 37231285
[TBL] [Abstract][Full Text] [Related]
5. Current applications and future perspective of CRISPR/Cas9 gene editing in cancer.
Wang SW; Gao C; Zheng YM; Yi L; Lu JC; Huang XY; Cai JB; Zhang PF; Cui YH; Ke AW
Mol Cancer; 2022 Feb; 21(1):57. PubMed ID: 35189910
[TBL] [Abstract][Full Text] [Related]
6. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.
Vaghari-Tabari M; Hassanpour P; Sadeghsoltani F; Malakoti F; Alemi F; Qujeq D; Asemi Z; Yousefi B
Cell Mol Biol Lett; 2022 Jun; 27(1):49. PubMed ID: 35715750
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
Li C; Brant E; Budak H; Zhang B
J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9 for cancer research and therapy.
Zhan T; Rindtorff N; Betge J; Ebert MP; Boutros M
Semin Cancer Biol; 2019 Apr; 55():106-119. PubMed ID: 29673923
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
11. Identifying synthetic lethal targets using CRISPR/Cas9 system.
Dhanjal JK; Radhakrishnan N; Sundar D
Methods; 2017 Dec; 131():66-73. PubMed ID: 28710008
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing.
Gostimskaya I
Biochemistry (Mosc); 2022 Aug; 87(8):777-788. PubMed ID: 36171658
[TBL] [Abstract][Full Text] [Related]
13. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery.
Ahmad G; Amiji M
Drug Discov Today; 2018 Mar; 23(3):519-533. PubMed ID: 29326075
[TBL] [Abstract][Full Text] [Related]
14. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology.
Mahato RK; Bhattacharya S; Khullar N; Sidhu IS; Reddy PH; Bhatti GK; Bhatti JS
J Biotechnol; 2024 Jan; 379():98-119. PubMed ID: 38065367
[TBL] [Abstract][Full Text] [Related]
15. The role of the CRISPR-Cas system in cancer drug development: Mechanisms of action and therapy.
Chandrasekaran AP; Karapurkar JK; Chung HY; Ramakrishna S
Biotechnol J; 2022 Jul; 17(7):e2100468. PubMed ID: 35157790
[TBL] [Abstract][Full Text] [Related]
16. High-throughput genetic screens using CRISPR-Cas9 system.
Kweon J; Kim Y
Arch Pharm Res; 2018 Sep; 41(9):875-884. PubMed ID: 29637495
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9: from Genome Editing to Cancer Research.
Chen S; Sun H; Miao K; Deng CX
Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
[TBL] [Abstract][Full Text] [Related]
18. Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering.
Wada N; Ueta R; Osakabe Y; Osakabe K
BMC Plant Biol; 2020 May; 20(1):234. PubMed ID: 32450802
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-based genome editing of zebrafish.
Sharma P; Sharma BS; Verma RJ
Prog Mol Biol Transl Sci; 2021; 180():69-84. PubMed ID: 33934838
[TBL] [Abstract][Full Text] [Related]
20. Genome Editing with CRISPR-Cas9: A Budding Biological Contrivance for Colorectal Carcinoma Research and its Perspective in Molecular Medicine.
Ray SK; Mukherjee S
Curr Mol Med; 2021; 21(6):462-475. PubMed ID: 33213345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
